Cedars-Sinai Technology Ventures

Last week, we had the privilege of hosting over 60+ members of the Swissenov Delegation in collaboration with Pascal Detemmerman at our offices, including leaders from France, Switzerland and Belgium. It was an inspiring exchange of ideas, innovation, and collaboration. A special thank you to our esteemed Cedars-Sinai speakers for making this visit truly unforgettable: ? Dr. Jeffrey Golden, Executive Vice Dean, Research and Research Education, Cedars-Sinai ? Mouneer Odeh , Vice President, Chief Data and AI Officer, Cedars-Sinai ? Dr. Shaun Miller, MD, MBA , Chief Health Informatics Officer, Cedars-Sinai ? Nirdesh K Gupta, PhD , Managing Partner, Cedars-Sinai Technology Ventures ? Rohit Rajkumar Rajkumar, Director, Business Development, Cedars-Sinai Health Ventures ? Rithik Jain Jain, Start-up Recruitment Lead Grateful for the opportunity to facilitate meaningful discussions and strengthen global partnerships. Looking forward to continued collaboration.

Last week, Cedars-Sinai Technology Ventures, in collaboration with the The Cedars-Sinai Accelerator, had the privilege of hosting an impactful Netherlands HealthTech Mini Accelerator Program alongside ScaleNL and NBSO Los Angeles. This immersive week provided a valuable platform for Dutch startups to engage with Cedars-Sinai healthcare professionals, gaining critical insights into the complexities of the U.S. market and refining their strategies for success. A special thank you to the participating companies—Ansana @AtMoves, @CC Diagnostics, and Neolook Solutions —for sharing your groundbreaking innovations with us. It was truly inspiring to learn about your work and its potential to transform healthcare. We sincerely appreciate Kinshuk Kocher, Manager of Investments and Special Projects, Julien Brohan, Director of Business Development, and Alex Chai, ?Executive Director, Technology Ventures Legal for Cedars-SInai, for their unwavering dedication in one-on-one sessions that have been pivotal in propelling these startups forward. A special thank you as well to Wenyue Du, PhD, CLP, Director of Business Development, for expertly moderating the session, "Innovation to Impact: Translating Discoveries into Successful Treatments.” We also extend our gratitude to ScaleNL and NBSO Los Angeles, including @Michael D. , Kaoutar Ashour, @Peter Post, Pim Schimmel, and the entire team, for your dedication in making this program so impactful. Here’s to continued collaboration and advancing health innovation together!

We are proud to co-invest $2 million alongside Oxford Science Enterprises to support Neu Health’s expansion into the U.S. market. With a decade of Oxford research and clinical validation, Neu Health’s platform empowers clinicians and patients—particularly those with Parkinson’s and dementia—to take an active role in their care. As part of this partnership, Cedars-Sinai will pilot the platform with 150 patients, advancing our mission to drive innovation and expand access to high-quality neurology care. Learn more below:

A Dutch delegation led by Minister of Economic Affairs Dirk Beljaarts met with Cedars-Sinai Technology Ventures, which confirmed our intention to establish a fund in the Netherlands in collaboration with the Netherlands Foreign Investment Agency. This partnership will provide Dutch companies and start-ups with access to a strategic network, knowledge and financing opportunities that will help accelerate innovation and growth in this crucial sector. https://lnkd.in/g9FQsJsE

Happy New Year!

Yesterday we welcomed a delegation of inspiring Italian women-led startups in health tech and green tech. Organized by Nuleep and the Italian Trade Agency, and US Market Access, this gathering brought together visionaries dedicated to advancing healthcare and sustainability. The event featured an interactive roundtable discussion on the future of health tech and sustainable innovation, with invaluable insights from industry leaders and startup founders. This was more than just a meeting—it was a glimpse into the future of healthcare and sustainability, with global perspectives and collaborative energy driving meaningful conversations. A heartfelt thank you to our partners The Italian Trade Agency - Los Angeles Office, particularly Sebastiano Peluso, Stefano Reppucci, @Alfredo Coppola, and Grace Park, for their exceptional support and dedication through the #GlobalStartupProgram. Their commitment to fostering international connections was instrumental in bringing these groundbreaking ideas to our community. Thank you to our Cedars-Sinai team for their invaluable contributions: ? Sean Collins, Executive Director of Facilities Planning, Design and Construction, Cedars-Sinai ? Erin Jackson-Ward, DrPH, Executive Director, Grantmaking and Social Impact ? Mark Rojas, Executive Director, Plant Operations and Engineering Services ? Julien Brohan, Manager, Business Development and Licensing, Cedars-Sinai Technology Ventures ? Wenyue Du, PhD, CLP, Manager, Business Development and Licensing, Cedars-Sinai Technology Ventures ? Emily Mack, Program Manager, Global Alliances, Cedars-Sinai Technology Ventures ? Michael Adame, Program Coordinator, Cedars-Sinai Technology Ventures ? Rithik Jain, Startup Recruitment Lead, Cedars-Sinai Accelerator

Congratulations to everyone – your achievements speak for themselves, and we couldn’t have said it better!

As the The Cedars-Sinai Accelerator approaches the conclusion of their Class 10 program, the Cedars-Sinai Technology Ventures team congratulates them for their dedication.?Cedars-Sinai Technology Ventures is proud to have contributed and offered insights to help guide these 10 very promising companies. We extend our gratitude to Kinshuk Kocher, manager of investments and special projects, Julien Brohan, manager of business development and licensing, and Nirdesh K Gupta, PhD, Managing Director, Cedars-Sinai Technology Ventures, whose relentless efforts in one-on-one sessions have been instrumental in driving these startups forward. Additionally, to Wenyue Du, PhD, CLP, manager of business development and licensing, for moderating the session, "Innovation to Impact: Advancing Healthcare through Cedars-Sinai Research and Clinical Trials."?? ?As we continue to build momentum, all eyes are on Demo Day at HLTH USA where we look forward to showcasing the future of healthcare innovation. We hope to see you there!

Introducing Cedars-Sinai Technology Ventures: The Spectrum of Innovation Brochure. We are proud to unveil our latest initiative that embodies our commitment to advancing healthcare through cutting-edge innovation. The Spectrum of Innovation brochure highlights our focus on groundbreaking medical technologies that have the potential to revolutionize healthcare and significantly improve patient outcomes. Globally, life expectancy has more than doubled in the last 200 years. This extraordinary progress is due not only to socio-economic advancements but also to remarkable innovations in medicine. At Cedars-Sinai Technology Ventures, we are dedicated to driving forward these innovations—precision medicine, genome editing, nanomedicine, regenerative medicine, and mRNA vaccines—along with emerging fields like virtual reality, augmented reality, and generative AI. Our investments in forward-thinking biomedical science along the entire spectrum of innovation are aimed at transforming ideas into healing, ultimately contributing to longer, healthier lives. This is our mission. This is our vision. Explore how we are shaping the future of healthcare in our new Spectrum of Innovation brochure. Together, we can transform the landscape of medicine.

Congratulations to?Aevice Health?on successfully closing their Seed Plus round, with significant participation from Coronet Ventures, our Singapore-based investment fund. This US$7 million investment is a pivotal step towards their success. Cedars-Sinai Technology Ventures?is excited to support?Aevice Health’s team through various initiatives that will engage key stakeholders across Cedars-Sinai, including?Dr. Irina Dralyuk?from?Guerin Children’s,?Colin Tan?from Coronet Ventures, and?Jian Tajbakhsh, PhD,?Omar Perez, and?Julien Brohan?from?Cedars-Sinai Technology Ventures. We look forward to collaborating closely to advance the management of chronic respiratory diseases. A special thanks to all the participating investors—Coronet Ventures,?East Ventures,?SEEDS Capital,?A&D Company,?NTUitive,?Farquhar VC (FVC), and?@Silicon Solution Partners—for their commitment to this shared vision.